Objective Juvenile idiopathic inflammatory myopathies (JIIM) are a group of connective
tissue disorders characterized by muscle inflammation and variable systemic involvement …

Macrophage activation syndrome or MAS, known by several names, is an acute severe
inflammatory syndrome that is often secondary to multiple autoimmune and …

Abstract Background/Objectives Janus kinase (JAK) inhibitors have been increasingly used
in the treatment of juvenile dermatomyositis (JDM). This review aims to comprehensively …

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5+
DM) is an infrequent autoimmune disease, which mainly distributes in Asians and females …

Background Macrophage activation syndrome (MAS) is a severe and life-threatening
syndrome associated with autoimmune diseases. The coexistence of MAS and juvenile …

There is no clear consensus in the literature regarding the choice of biologic therapies and
efficacy in juvenile dermatomyositis (JDM). In this review, we aimed to examine previous …

Objective To explore the clinical features and prognoses of dermatomyositis (DM)
associated with a double-positive anti-MDA5 and anti-aminoacyl-tRNA synthetase (anti …

Background Macrophage activation syndrome (MAS) is a serve complication of juvenile
idiopathic inflammatory myopathies (JIIMs). This study delineates the clinical manifestations …

Background The present study aims to evaluate possible cardiac involvement in juvenile
dermatomyositis (JDM) patients by conventional methods and cardiac magnetic resonance …

Juvenile idiopathic inflammatory myopathy (JIIM) is a rare systemic autoimmune disease
characterized by skeletal muscle weakness with or without a skin rash. Juvenile …